美股市场个股详情
SUPN Supernus Pharmaceuticals
- 30.830
- +0.560+1.85%
收盘价 05/03 16:00 (美东)
16.95亿总市值1541.50市盈率TTM
30.910最高价30.000最低价36.24万股成交量30.740今开30.270昨收1107.65万成交额0.76%换手率1541.50市盈率(静)5497.38万总股本35.96052周最高1.84市净率14.78亿流通值21.99052周最低--股息TTM4794.49万流通股61.250历史最高--股息率TTM3.01%振幅4.300历史最低30.562平均价1股每手
Supernus Pharmaceuticals关键统计数据
季报+年报
显示同比
| (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | (Q1)2023/03/31 | (FY)2022/12/31 | (Q4)2022/12/31 | (Q3)2022/09/30 | (Q2)2022/06/30 | (Q1)2022/03/31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | -8.95%6.08亿 | -1.80%1.64亿 | -13.24%1.54亿 | -20.28%1.36亿 | 0.82%1.54亿 | 15.09%6.67亿 | 5.20%1.67亿 | 19.46%1.77亿 | 20.32%1.7亿 | 16.48%1.53亿 |
| 营业收入 | -8.95%6.08亿 | -1.80%1.64亿 | -13.24%1.54亿 | -20.28%1.36亿 | 0.82%1.54亿 | 15.09%6.67亿 | 5.20%1.67亿 | 19.46%1.77亿 | 20.32%1.7亿 | 16.48%1.53亿 |
| 主营业务成本 | -3.95%8,377.9万 | -14.49%1,962.7万 | -24.26%1,960.1万 | 3.10%2,109.1万 | 30.83%2,346万 | 16.20%8,722.1万 | 35.07%2,295.4万 | 43.09%2,587.8万 | -18.26%2,045.7万 | 19.91%1,793.2万 |
| 毛利 | -9.70%5.24亿 | 0.22%1.45亿 | -11.35%1.34亿 | -23.48%1.14亿 | -3.17%1.3亿 | 14.92%5.8亿 | 1.63%1.44亿 | 16.18%1.51亿 | 28.63%1.5亿 | 16.03%1.35亿 |
| 营业费用 | -4.50%5.1亿 | 11.79%1.26亿 | -16.99%1.27亿 | -4.54%1.31亿 | -3.92%1.27亿 | 25.68%5.34亿 | -16.61%1.12亿 | 56.11%1.53亿 | 51.21%1.38亿 | 29.68%1.32亿 |
| 销售和管理费用 | -10.83%3.36亿 | 9.88%8,128.2万 | -26.37%8,270万 | -13.63%8,678.2万 | -5.37%8,559.7万 | 23.78%3.77亿 | -27.29%7,397.2万 | 55.92%1.12亿 | 44.50%1亿 | 47.19%9,045.9万 |
| -销售费用 | -14.42%2.29亿 | 15.18%5,527.7万 | -33.74%5,678.5万 | -18.60%5,989.4万 | -5.43%5,723万 | --2.68亿 | --4,799万 | 69.03%8,570.4万 | 52.09%7,358.1万 | 57.39%6,051.3万 |
| -管理费用 | -2.06%1.07亿 | 0.09%2,600.5万 | -2.61%2,591.5万 | -0.03%2,688.8万 | -5.27%2,836.7万 | --1.09亿 | --2,598.2万 | 24.77%2,661万 | 27.13%2,689.5万 | 30.14%2,994.6万 |
| 研发费用 | 22.86%9,159.3万 | 31.35%2,334.7万 | 15.86%2,265.5万 | 48.79%2,437.9万 | 1.79%2,121.2万 | -17.59%7,455.2万 | -15.68%1,777.4万 | -0.51%1,955.4万 | 6.02%1,638.5万 | -39.21%2,083.9万 |
| 折旧摊销及损耗 | -0.30%8,238.5万 | 1.79%2,106.9万 | 2.90%2,124.2万 | -2.60%2,010.8万 | -3.28%1,996.6万 | 175.53%8,263万 | 72.12%2,069.8万 | 243.55%2,064.4万 | 247.07%2,064.4万 | 243.67%2,064.4万 |
| -折旧及摊销 | -0.30%8,238.5万 | 1.79%2,106.9万 | 2.90%2,124.2万 | -2.60%2,010.8万 | -3.28%1,996.6万 | 175.53%8,263万 | 72.12%2,069.8万 | 243.55%2,064.4万 | 247.07%2,064.4万 | 243.67%2,064.4万 |
| 营业利润 | -70.62%1,340.3万 | -40.53%1,898.9万 | 840.79%768.2万 | -238.94%-1,679.7万 | 34.08%352.9万 | -42.62%4,561.4万 | 342.37%3,193万 | -103.17%-103.7万 | -52.34%1,208.9万 | -81.51%263.2万 |
| 净非营业利息收入（费用） | -45.02%803.8万 | 146.40%198.6万 | 62.28%175.1万 | 2,190.91%46万 | -69.89%384.1万 | 213.73%1,461.9万 | 119.92%80.6万 | 129.61%107.9万 | 99.24%-2.2万 | 658.25%1,275.6万 |
| 利息收入 | -51.81%1,045.3万 | -17.25%198.6万 | -37.53%175.1万 | -23.38%137万 | -63.63%534.6万 | 105.21%2,168.9万 | 27.19%240万 | 22.88%280.3万 | -30.94%178.8万 | 285.57%1,469.8万 |
| 利息费用 | -65.84%241.5万 | --0 | --0 | -49.72%91万 | -22.50%150.5万 | -69.82%707万 | -73.14%159.4万 | -70.90%172.4万 | -66.89%181万 | -68.15%194.2万 |
| 其他净收入（费用） | -3,761.18%-1,867.2万 | -931.32%-1,998.5万 | 193.83%45.6万 | -6.33%-79万 | 347.67%164.7万 | -92.19%51万 | 314.64%240.4万 | -507.50%-48.6万 | -108.49%-74.3万 | 34.80%-66.5万 |
| 特殊收入（费用） | -3,761.18%-1,867.2万 | -931.32%-1,998.5万 | 193.83%45.6万 | -6.33%-79万 | 347.67%164.7万 | -92.19%51万 | 314.64%240.4万 | -507.50%-48.6万 | -108.49%-74.3万 | 34.80%-66.5万 |
| -减：重组与并购 | -197.45%-151.7万 | 91.51%-20.4万 | -193.83%-45.6万 | 6.33%79万 | -347.67%-164.7万 | 92.19%-51万 | -314.64%-240.4万 | 507.50%48.6万 | 108.49%74.3万 | -34.80%66.5万 |
| -减：资本性资产减值 | --2,018.9万 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| 税前利润 | -95.44%276.9万 | -97.18%99万 | 2,327.25%988.9万 | -251.25%-1,712.7万 | -38.76%901.7万 | -16.99%6,074.3万 | 1,613.31%3,514万 | -101.53%-44.4万 | -63.75%1,132.4万 | 34.71%1,472.3万 |
| 所得税 | 4,440.63%145.3万 | -101.92%-18.5万 | 1,279.43%2,586.5万 | -571.12%-1,629.6万 | 27.19%-793.1万 | -99.84%3.2万 | 2,570.33%965.9万 | -129.64%-219.3万 | -53.94%345.9万 | -308.08%-1,089.3万 |
| 除税后利润 | -97.83%131.6万 | -95.39%117.5万 | -1,013.44%-1,597.6万 | -110.57%-83.1万 | -33.84%1,694.8万 | 13.64%6,071.1万 | 943.45%2,548.1万 | -91.89%174.9万 | -66.85%786.5万 | 349.88%2,561.6万 |
| 持续经营利润 | -97.83%131.6万 | -95.39%117.5万 | -1,013.44%-1,597.6万 | -110.57%-83.1万 | -33.84%1,694.8万 | 13.64%6,071.1万 | 943.45%2,548.1万 | -91.89%174.9万 | -66.85%786.5万 | 349.88%2,561.6万 |
| 归属于少数股东的净利润 | ||||||||||
| 归属于母公司的净利润 | -97.83%131.6万 | -95.39%117.5万 | -1,013.44%-1,597.6万 | -110.57%-83.1万 | -33.84%1,694.8万 | 13.64%6,071.1万 | 943.45%2,548.1万 | -91.89%174.9万 | -66.85%786.5万 | 349.88%2,561.6万 |
| 优先股派息 | ||||||||||
| 其他优先股派息 | ||||||||||
| 归属于普通股股东的净利润 | -97.83%131.6万 | -95.39%117.5万 | -1,013.44%-1,597.6万 | -110.57%-83.1万 | -33.84%1,694.8万 | 13.64%6,071.1万 | 943.45%2,548.1万 | -91.89%174.9万 | -66.85%786.5万 | 349.88%2,561.6万 |
| 基本每股收益 | -98.23%0.02 | -96.30%0.0174 | -1,066.67%-0.29 | -113.33%-0.02 | -35.42%0.31 | 11.88%1.13 | 840.00%0.47 | -92.68%0.03 | -66.67%0.15 | 336.36%0.48 |
| 稀释每股收益 | -98.08%0.02 | -95.95%0.0174 | -1,066.67%-0.29 | -114.29%-0.02 | -32.56%0.29 | 6.12%1.04 | 975.00%0.43 | -92.50%0.03 | -67.44%0.14 | 290.91%0.43 |
| 每股派息 | ||||||||||
| 货币单位 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
| 会计准则 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| 审计意见 | 无保留意见 | -- | -- | -- | -- | 无保留意见 | -- | -- | -- | -- |
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅